✦ LIBER ✦

Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non–ST-segment elevation acute coronary syndromes

✍ Scribed by M. Roffi; D.P. Chew; D. Mukherjee

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intravenous glycoprotein IIb/IIIa inhibi

✍ Derek P Chew; Marco Roffi; Eric J Topol 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 121 KB

Glycoprotein IIb-IIIa Inhibitors in the

✍ Cedric W. Lefebvre; James W. Hoekstra; Marc Bonaca; Robert Giugliano 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Early Glycoprotein IIb/IIIa Inhibitor Us

✍ James W. Hoekstra; Matthew T. Roe; Eric D. Peterson; Venu Menon; Jyotsna Mulgund 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

Use of platelet glycoprotein IIb/IIIa in

✍ Eddy S. Lang; Marc Afilalo 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Administration of Glycoprotein IIb-IIIa

✍ Paul P. Dobesh; Jennifer B. Kasiar 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB

Use of platelet glycoprotein IIb/IIIa in

✍ Timm Bauer; Helge Möllmann; Franz Weidinger; Uwe Zeymer; Ricardo Seabra-Gomes; F 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 302 KB